Adenosine: Clinical Trials

70 trials of Adenosine, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

40 completed, 8 recruiting, 8 terminated, 8 unknown. 17 Not applicable, 17 Phase 3, 14 Phase 2, 9 Phase 1, 8 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable17Completed 12, Active not recruiting 1, Recruiting 1, Suspended 1, Unknown 1, Withdrawn 1
Phase 317Completed 11, Terminated 3, Recruiting 1, Unknown 1, Withdrawn 1
Phase 214Completed 7, Unknown 4, Terminated 2, Withdrawn 1
Phase 19Completed 6, Terminated 2, Unknown 1
Phase 48Recruiting 4, Completed 3, Terminated 1
Early Phase 13Completed 2, Recruiting 1

Follow Adenosine: new trials by email Literature Review of Adenosine trials Research Report on Adenosine

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Reducing Slow/No-Reflow With Prophylactic High-Dose Intracoronary Adenosine Protocol in ST-Elevation Myocardial Infarction The REFLOW AMI Trial
Adenosine, Standard Treatment only - ST-Elevation Myocardial Infarction (STEMI)
Not applicableRecruitingProf Muzaffar Ali Zahidi6602026-08-142026-10-27
Adenosine vs Diltiazem for Treatment of SVT in the ED
adenosine, diltiazem - Supraventricular Tachycardia (SVT)
Phase 4RecruitingAnne E. Zepeski202025-08-012026-05-28
PERceptions of Diltiazem Versus ADEnosine for Treatment of Supraventricular Tachycardia in the Emergency Department
IV adenosine, IV diltiazem - Supraventricular Tachycardia (SVT)
RecruitingUniversity of Iowa1002025-04-042026-08-21
Efficacy of Adenosine as Compared to Verapamil in Paroxysmal Supraventricular Tachycardia (pSVT) Patients
Adenosine, Verapamil Injection - Supraventricular Tachycardia (SVtach)
Phase 3RecruitingRashid Latif Medical College2102024-10-282024-12-13
Hyperemic mYocardial Perfusion by adEnosine at diffeRent Doses
Adenosine - Chronic Coronary Syndrome, Coronary Artery Disease
Phase 4RecruitingRegion Skane1802024-10-232026-08-13
The ARCTIC Trial: Aerosolized Inhaled Adenosine Treatment in Patients With Acute Respiratory Distress Syndrome (ARDS) Caused by COVID-19
Adenosine - Acute Respiratory Distress
Phase 2WithdrawnUniversity of Florida2023-12-012024-05-06
Adenosine's Effect on STunning Resolution in Acute Myocardial Infarction
Adenosine - Myocardial Ischemia
Phase 3WithdrawnVastra Gotaland Region2023-01-012024-05-17
Adrenaline for the Treatment of No-Reflow in Normotensive Patients
Adrenaline, Adenosine - Acute Coronary Syndrome, No-Reflow Phenomenon
Phase 4CompletedNational Institute of Cardiovascular Diseases, Pakistan2012021-01-012021-05-21
BROKEN-SWEDEHEART- Optimized Pharmacological Treatment for Broken Heart (Takotsubo) Syndrome.
Adenosine, Dipyridamole 200 mg, Apixaban 5 mg Oral Tablet - Takotsubo Syndrome
Phase 4RecruitingVastra Gotaland Region10002020-12-142024-12-02
The Effect of Adenosine on Cranial Hemodynamic, Headache and Migraine Induction Properties.
Adenosine, Saline - Headache, Migraine
Not applicableCompletedDanish Headache Center182020-11-012022-11-16
Adenosine Versus Verapamil for Management of Supraventricular Tachycardia Post- Coronary Artery Bypass Grafting
adenosine, verapamil - Supraventricular Tachycardia
Not applicableCompletedAin Shams University2682020-02-012020-12-02
Pyridoxine, P2 Receptor Antagonism, and ATP-mediated Vasodilation in Young Adults
Adenosine Triphosphate, Acetylcholine, Sodium Nitroprusside - Receptor Blockade
Early Phase 1CompletedColorado State University92019-02-072021-07-27
Adenosine Contrast CorrELations in Evaluating RevAscularizaTION
Iopamidol, adenosine, Navvus® Catheter - Percutaneous Coronary Intervention
Phase 4CompletedDuke University2012019-01-172024-07-05
A Single Center Diagnostic, Cross-sectional Study of Coronary Microvascular Dysfunction
Bivalirudin, Adenosine, Heparin - Coronary Microvascular Disease, Ischemic Heart Disease
Not applicableActive not recruitingNYU Langone Health2062018-06-292025-11-28
Stress Test in Detecting Heart Damage in Premenopausal Women With Stage I-III Breast Cancer
Adenosine, Magnetic Resonance Imaging, Regadenoson - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8
CompletedWake Forest University Health Sciences252018-06-212026-01-29
Management of Supraventricular Tachycardia of Children
adenosine,Propranolol,flecainide, amiodarone, propranolol, digoxin and procainamide. - Supraventricular Tachycardia
UnknownAssiut University502018-05-152018-05-18
A Trial to Compare American Heart Association (AHA) and Simple (SIM)Method to Give Adenosine to Treat Supra-ventricular Tachycardia (SVT)
Adenosine - Supra-ventricular Tachycardia
Phase 3CompletedUniversity of Pretoria302018-04-012021-06-25
Whole-Heart Myocardial Blood Flow Quantification Using MRI
Myocardial Perfusion Cardiac MRI., Contrast, Pharmacologic Stress Agent - Coronary Artery Disease, Coronary Microvascular Disease
UnknownCedars-Sinai Medical Center1602018-03-012023-02-08
A Dose Titration Study to Assess the Effects of SAR407899 in Patients With MVA and/or Persistent Stable Angina Despite Angiographically Successful PCI
SAR407899, Placebo, Adenosine - Microvascular Coronary Artery Disease
Phase 2TerminatedSanofi102017-10-122022-03-24
Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve
Regadenoson, Adenosine - Hypertrophic Cardiomyopathy, Non-ischemic Dilated Cardiomyopathy
Phase 4TerminatedDuke University312017-09-052020-09-16

Showing 20 of 70. Sign in to see all of them.

Conditions studied

Coronary Artery Disease (18)  ·  Myocardial Ischemia (10)  ·  Tachycardia, Supraventricular (7)  ·  Ischemia (4)  ·  Angina Pectoris (3)  ·  Inflammation (2)  ·  Microvascular Angina (2)  ·  Obesity (2)  ·  Reperfusion Injury (2)  ·  Takotsubo Cardiomyopathy (2)  ·  Acute Coronary Syndrome (1)  ·  Acute Lung Injury (1)  ·  Angina, Stable (1)  ·  Atherosclerosis (1)  ·  Atrial Fibrillation (1)

Sponsors

University of Utah (3)  ·  Cedars-Sinai Medical Center (2)  ·  Duke University (2)  ·  Forest Laboratories (2)  ·  Gilead Sciences (2)  ·  Pfizer (2)  ·  Radboud University Medical Center (2)  ·  Vanderbilt University (2)  ·  Vastra Gotaland Region (2)  ·  Wake Forest University Health Sciences (2)  ·  Adenobio N.V (1)  ·  Ain Shams University (1)  ·  Amphia Hospital (1)  ·  Anne E. Zepeski (1)  ·  Assiut University (1)

Countries

United States (33)  ·  Netherlands (7)  ·  Denmark (5)  ·  Italy (5)  ·  Sweden (4)  ·  Belgium (3)  ·  Pakistan (3)  ·  Brazil (2)  ·  Canada (2)  ·  France (2)  ·  Norway (2)  ·  South Korea (2)  ·  United Kingdom (2)  ·  Argentina (1)  ·  Austria (1)

Top investigators

David B Bharucha, MD, PhD, FACC (2)  ·  Edward DiBella, Ph.D. (2)  ·  Gerard Rongen, MD, PhD (2)  ·  Italo Biaggioni, M.D. (2)  ·  Robert L. Rolleri, Pharm.D. (2)  ·  Anne Zepeski, PharmD (1)  ·  B. Bravenboer, MD, PhD (1)  ·  Brian B Ghoshhajra, MD (1)  ·  Bruce Spiess (1)  ·  Bryan Goldstein, MD (1)  ·  Debiao Li, PhD (1)  ·  Elmir Omerovic, MD PhD (1)

Results publications

PMID 17826318, PMID 19744616, PMID 19936863, PMID 20093513, PMID 21196444, PMID 21697134, PMID 21968545, PMID 22000773, PMID 22146505, PMID 22210535, PMID 22222164, PMID 22964356, PMID 23051145, PMID 25136887, PMID 25449504, PMID 25977304, PMID 26068287, PMID 26242981, PMID 26577263, PMID 27013162, PMID 27101902, PMID 27282899, PMID 27435894, PMID 28086778, PMID 28450351, PMID 28728652, PMID 29042397, PMID 29050557, PMID 29361484, PMID 30115688, PMID 34335296, PMID 34503740, PMID 34503741, PMID 35000456, PMID 36251971, PMID 36435233, PMID 37264699, PMID 38583174, PMID 39234878, PMID 40270240, PMID 9426034

NIH funding

2008 (1), 2009 (1), 2015 (1), 2016 (1), 2023 (1), P01NS041386 (1), P30CA012197 (1), R01EB002623 (1), R01HL124649 (1), R01HL135328 (1)